Italian biotech company specialized in production of innovative recombinant lytic enzymes is looking to join a consortium for Horizon Europe call

Fecha de publicación: 24/12/2022
Fuente: Infoactis
Lugar: Tecnología - Demanda
Italian biotech SME committed to R&D, production and marketing of high quality lytic enzymes for cell therapy and regenerative medicine, currently offers services in particular screening and characterization of enzymes, engineering and development of novel recombinant proteins, in vitro and in vivo animal models for testing advanced therapies and medical devices. The company is looking to join a Horizon Europe research consortium under a research cooperation agreement.